Kowalski Piotr S, Capasso Palmiero Umberto, Huang Yuxuan, Rudra Arnab, Langer Robert, Anderson Daniel G
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
Adv Mater. 2018 Jul 5:e1801151. doi: 10.1002/adma.201801151.
The utility of messenger RNA (mRNA) as a therapy is gaining a broad interest due to its potential for addressing a wide range of diseases, while effective delivery of mRNA molecules to various tissues still poses a challenge. This study reports on the design and characterization of new ionizable amino-polyesters (APEs), synthesized via ring opening polymerization (ROP) of lactones with tertiary amino-alcohols that enable tissue and cell type selective delivery of mRNA. With a diverse library of APEs formulated into lipid nanoparticles (LNP), structure-activity parameters crucial for efficient transfection are established and APE-LNPs are identified that can preferentially home to and elicit effective mRNA expression with low in vivo toxicity in lung endothelium, liver hepatocytes, and splenic antigen presenting cells, including APE-LNP demonstrating nearly tenfold more potent systemic mRNA delivery to the lungs than vivo-jetPEI. Adopting tertiary amino-alcohols to initiate ROP of lactones allows to control polymer molecular weight and obtain amino-polyesters with narrow molecular weight distribution, exhibiting batch-to-batch consistency. All of which highlight the potential for clinical translation of APEs for systemic mRNA delivery and demonstrate the importance of employing controlled polymerization in the design of new polymeric nanomaterials to improve in vivo nucleic acid delivery.
信使核糖核酸(mRNA)作为一种治疗手段,因其在治疗多种疾病方面的潜力而受到广泛关注,然而,将mRNA分子有效递送至各种组织仍然是一项挑战。本研究报告了新型可电离氨基聚酯(APE)的设计与表征,该聚酯通过内酯与叔氨基醇的开环聚合(ROP)合成,能够实现mRNA的组织和细胞类型选择性递送。通过将多种APE库配制到脂质纳米颗粒(LNP)中,建立了高效转染所需的结构-活性参数,并鉴定出了能够优先归巢至肺内皮细胞、肝肝细胞和脾抗原呈递细胞,并在体内低毒性下引发有效mRNA表达的APE-LNP,其中一种APE-LNP向肺部的全身mRNA递送能力比体内注射用聚乙烯亚胺(vivo-jetPEI)强近十倍。采用叔氨基醇引发内酯的ROP反应,可以控制聚合物分子量并获得分子量分布窄的氨基聚酯,表现出批次间的一致性。所有这些都突出了APE用于全身mRNA递送的临床转化潜力,并证明了在新型聚合物纳米材料设计中采用可控聚合以改善体内核酸递送的重要性。